Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Lobeline, the principal lobelia alkaloid, is predominantly found in Lobelia chinensis, Lobelia inflata, Campanula medium, Lobelia hassleri, and Lobelia nicotianaefolia. Historically known as Indian tobacco, Lobelia inflata has been utilized for treating respiratory ailments and asthma by American Aborigines. In the 19th-century United States, it was employed as a vomiting agent to expel toxins, earning it the nickname "vomit grass." Today, Lobelia inflata continues to be used for clearing respiratory mucus from the throat, bronchial, lung, and other areas.

90-69-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 90-69-7 Structure
  • Basic information

    1. Product Name: Lobeline
    2. Synonyms: L-lobeline free base;Lobeline;LOBELIDINE95%,98%;LOBELINE HCl, a-(P);Lobeline (base and/or unspecified salts);(-)-α-[(2R,6S)-6-[(S)-β-hydroxyphenethyl]-1-methyl-2-piperidinyl]acetophenone;Inflatine;Lobelin
    3. CAS NO:90-69-7
    4. Molecular Formula: C22H27NO2
    5. Molecular Weight: 337.45528
    6. EINECS: 202-012-3
    7. Product Categories: N/A
    8. Mol File: 90-69-7.mol
  • Chemical Properties

    1. Melting Point: 130-131°
    2. Boiling Point: 473.76°C (rough estimate)
    3. Flash Point: 247.5oC
    4. Appearance: /
    5. Density: 1.0909 (rough estimate)
    6. Vapor Pressure: 3.05E-10mmHg at 25°C
    7. Refractive Index: 1.5614 (estimate)
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 14.34±0.20(Predicted)
    11. CAS DataBase Reference: Lobeline(CAS DataBase Reference)
    12. NIST Chemistry Reference: Lobeline(90-69-7)
    13. EPA Substance Registry System: Lobeline(90-69-7)
  • Safety Data

    1. Hazard Codes: T
    2. Statements: 23/24/25
    3. Safety Statements: 36/37/39-45
    4. RIDADR: 1544
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: 6.1(b)
    8. PackingGroup: III
    9. Hazardous Substances Data: 90-69-7(Hazardous Substances Data)

90-69-7 Usage

Uses

Used in Pharmaceutical Industry:
Lobeline is used as a respiratory stimulant for treating respiratory diseases and conditions.
Used in Anti-smoking Products:
Lobeline's sulfate salt is utilized in antismoking tablets, aiding in smoking cessation efforts.

History

In the 1930s, the chemical synthesis process of lobeline was completed, and its artificial synthesis was realized, which was found in Lobelia inflata from the North American Campanulaceae. It was commonly used as a lobeline hydrochloride. Because of its structure similar to nicotine, it was initially used for the treatment of respiratory diseases. Further study found that lobeline can selectively excite the carotid sinus peripheral chemoreceptors, then reflect the excitement of the medullary breathing center, and enhance respiratory function. Therefore, it is widely used as a respiratory stimulant .Although lobeline showed similar biological activity with nicotine, its potency is just only 1/5~1/20 of nicotine. Hence, lobeline was used as a substitute for nicotine in many smoking cessation products. However, in 1993, the Food and Drug Administration (FDA) banned the sale of smoking cessation products containing lobeline because it was ineffective in helping people quit smoking. However, the research of lobeline in drug addiction still continues.

Indications

Lobeline was recorded in chemical drug and preparations as lobeline hydrochloride, which is prepared as injection for the treatment of central respiratory inhibition induced by a variety of reasons. In addition, it is also used for the treatment of neonatal stasis, carbon monoxide, opioid poisoning, and so on.

Health Hazard

The structure of lobeline is different fromthose of nicotine and anabasine. It does nothave a pyridine ring, similar to the lattertwo alkaloids. However, its pharmacologicaction is similar to but less potent than thatof nicotine. Like anabasine, it is a respiratorystimulant. The toxic symptoms includeincreased salivation, nausea, vomiting, diarrhea,and respiratory distress.

Pharmacology

The pharmacological effects of lobeline are extensive, mainly manifested as nicotine-like effect. On the one hand, lobeline can selectively excite the carotid sinus and aortic body chemoreceptors and induce reflective excitement of the respiratory center and vagus center. Lobeline showed better excitatory effect for the respiratory inhibition caused by morphine. There is bronchiectasis effect directly when lobeline is inhaled, hence, against pilocarpine and acetylcholine-induced tracheal contraction. When the dose increased, lobeline can directly stimulate the respiratory center and excite vagal center (reducing heart rate) and vomiting center in medulla oblongata. In addition, lobeline showed dual role in the regulation of ganglion, as manifested excitement and inhibition in chronological order. Lobeline has a zebra-like effect on the striated muscle. In addition, it also has a certain anticancer effect, as manifested by significantly inhibiting the uptake of oxygen in mouse ascites cancer cells .

Clinical Use

It is mainly used in the treatment of (1) neonatal asphyxia, (2) suffocation caused by carbon monoxide, (3) poisoning induced by inhalation of anesthetics and other central inhibitors (such as opioids and barbiturates), and (4) respiratory failure caused by pneumonia, diphtheria, and other infectious diseases.

Side effects

Lobeline also showed side effects, such as nausea, vomiting, cough, headache, palpitations, and other adverse reactions.

Check Digit Verification of cas no

The CAS Registry Mumber 90-69-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 0 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 90-69:
(4*9)+(3*0)+(2*6)+(1*9)=57
57 % 10 = 7
So 90-69-7 is a valid CAS Registry Number.
InChI:InChI=1/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3

90-69-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-lobeline

1.2 Other means of identification

Product number -
Other names Ethanone, 2-[6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl]-1-phenyl-, [2R-[2α,6α(S*)]]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:90-69-7 SDS

90-69-7Synthetic route

Lobelanine
579-21-5

Lobelanine

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With ammonium formate In 1,2-dichloro-ethane at 75℃; for 1h; Inert atmosphere;91%
2-{(6S)-6-[(2S)-2-(tert-butyldimethylsilanoxy)-2-phenylethyl]-1-methylpiperidin-(2R)-2-yl}-1-phenylethanone

2-{(6S)-6-[(2S)-2-(tert-butyldimethylsilanoxy)-2-phenylethyl]-1-methylpiperidin-(2R)-2-yl}-1-phenylethanone

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With hydrogenchloride In water; isopropyl alcohol at 60℃; for 12h;90%
C32H49NO3SSi

C32H49NO3SSi

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With hydrogenchloride In methanol; water for 0.5h; Large scale;88%
(+/-)-Lobelanine hydrochloride

(+/-)-Lobelanine hydrochloride

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Stage #1: (+/-)-Lobelanine hydrochloride With hydrogen; triethylamine; chloro(1,5-cyclooctadiene)rhodium(I) dimer; (2R,4R)-4-(dicyclohexylphosphino)-2-(diphenylphosphino-methyl)-N-methyl-aminocarbonyl-pyrrolidine In methanol at 47 - 53℃; under 525.053 - 97584.8 Torr; Industry scale;
Stage #2: With hydrogenchloride In water; toluene at 35 - 40℃; for 0.333333h; pH=0.5 - 1.5;
Stage #3: With sodium hydroxide In water; toluene at 35 - 40℃; for 0.333333h; pH=12 - 13;
29%
Lobeline hydrochloride
134-63-4

Lobeline hydrochloride

A

(2S)-Lobeline

(2S)-Lobeline

B

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With sodium hydrogencarbonate In water for 48h;
(2S,6S,2R)-2-<6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl>-1-phenylethan-<1,3>-dioxolane
237059-21-1

(2S,6S,2R)-2-<6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl>-1-phenylethan-<1,3>-dioxolane

A

(2S)-Lobeline

(2S)-Lobeline

B

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With hydrogenchloride Heating; Yield given; Yields of byproduct given;
(1S)-2-((S)-oxiranyl)-1-phenylethanol
491837-37-7

(1S)-2-((S)-oxiranyl)-1-phenylethanol

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: 96 percent / triethylamine; 4-(dimethylamino)pyridine / dimethylformamide / 3 h / 20 °C
2.1: CuI / diethyl ether / 0.25 h / -30 °C
2.2: 92 percent / diethyl ether / 0.5 h / -40 °C
3.1: 97 percent / triethylamine / CH2Cl2 / 0.17 h / 0 °C
4.1: 88 percent / dimethylformamide; H2O / 20 h / 50 °C
5.1: 95 percent / triethylamine / CH2Cl2 / 6 h / 20 °C
6.1: tetrahydrofuran / 0 - 20 °C
7.1: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
8.1: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
9.1: 82 percent / tetrahydrofuran / 13 h / 65 °C
10.1: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(1S,3S)-tert-butyldimethyl(2-oxiranyl-1-phenylethoxy)silane
491837-39-9

(1S,3S)-tert-butyldimethyl(2-oxiranyl-1-phenylethoxy)silane

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: CuI / diethyl ether / 0.25 h / -30 °C
1.2: 92 percent / diethyl ether / 0.5 h / -40 °C
2.1: 97 percent / triethylamine / CH2Cl2 / 0.17 h / 0 °C
3.1: 88 percent / dimethylformamide; H2O / 20 h / 50 °C
4.1: 95 percent / triethylamine / CH2Cl2 / 6 h / 20 °C
5.1: tetrahydrofuran / 0 - 20 °C
6.1: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
7.1: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
8.1: 82 percent / tetrahydrofuran / 13 h / 65 °C
9.1: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(1S,3S)-4-nitrobenzoic acid 2-oxiranyl-1-phenylethyl ester
491837-38-8

(1S,3S)-4-nitrobenzoic acid 2-oxiranyl-1-phenylethyl ester

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 11 steps
1.1: 77 percent / K2CO3; methanol / H2O / 2 h / 20 °C
2.1: 96 percent / triethylamine; 4-(dimethylamino)pyridine / dimethylformamide / 3 h / 20 °C
3.1: CuI / diethyl ether / 0.25 h / -30 °C
3.2: 92 percent / diethyl ether / 0.5 h / -40 °C
4.1: 97 percent / triethylamine / CH2Cl2 / 0.17 h / 0 °C
5.1: 88 percent / dimethylformamide; H2O / 20 h / 50 °C
6.1: 95 percent / triethylamine / CH2Cl2 / 6 h / 20 °C
7.1: tetrahydrofuran / 0 - 20 °C
8.1: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
9.1: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
10.1: 82 percent / tetrahydrofuran / 13 h / 65 °C
11.1: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(1S,3R)-1-(tert-butyldimethylsilanoxy)-1-phenylhept-6-en-3-ol
491837-40-2

(1S,3R)-1-(tert-butyldimethylsilanoxy)-1-phenylhept-6-en-3-ol

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 97 percent / triethylamine / CH2Cl2 / 0.17 h / 0 °C
2: 88 percent / dimethylformamide; H2O / 20 h / 50 °C
3: 95 percent / triethylamine / CH2Cl2 / 6 h / 20 °C
4: tetrahydrofuran / 0 - 20 °C
5: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
6: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
7: 82 percent / tetrahydrofuran / 13 h / 65 °C
8: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]pent-4-enyl}methylamine
491837-42-4

(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]pent-4-enyl}methylamine

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 95 percent / triethylamine / CH2Cl2 / 6 h / 20 °C
2: tetrahydrofuran / 0 - 20 °C
3: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
4: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
5: 82 percent / tetrahydrofuran / 13 h / 65 °C
6: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(2'S,1R)-methanesulfonic acid 1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]pent-4-enyl ester
491837-41-3

(2'S,1R)-methanesulfonic acid 1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]pent-4-enyl ester

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 88 percent / dimethylformamide; H2O / 20 h / 50 °C
2: 95 percent / triethylamine / CH2Cl2 / 6 h / 20 °C
3: tetrahydrofuran / 0 - 20 °C
4: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
5: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
6: 82 percent / tetrahydrofuran / 13 h / 65 °C
7: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]-5-oxopentyl}methylcarbamic acid tert-butyl ester
491837-46-8

(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]-5-oxopentyl}methylcarbamic acid tert-butyl ester

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 82 percent / tetrahydrofuran / 13 h / 65 °C
2: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]pent-4-enyl}methylcarbamic acid tert-butyl ester
491837-43-5

(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]pent-4-enyl}methylcarbamic acid tert-butyl ester

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: tetrahydrofuran / 0 - 20 °C
2: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
3: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
4: 82 percent / tetrahydrofuran / 13 h / 65 °C
5: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]-5-hydroxypentyl}methylcarbamic acid tert-butyl ester
491837-44-6

(2'S,1S)-{1-[2-(tert-butyldimethylsilanoxy)-2-phenylethyl]-5-hydroxypentyl}methylcarbamic acid tert-butyl ester

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
2: 82 percent / tetrahydrofuran / 13 h / 65 °C
3: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
{1-[2-(tert-butyl-dimethyl-silanyloxy)-2-phenyl-ethyl]-5-dicyclohexylboranyl-pentyl}-methyl-carbamic acid tert-butyl ester

{1-[2-(tert-butyl-dimethyl-silanyloxy)-2-phenyl-ethyl]-5-dicyclohexylboranyl-pentyl}-methyl-carbamic acid tert-butyl ester

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.83 g / NaOH; H2O2 / H2O; ethanol; tetrahydrofuran / 1 h / 20 °C
2: 96 percent / Dess-Martin periodinane / CH2Cl2 / 0.25 h / 20 °C
3: 82 percent / tetrahydrofuran / 13 h / 65 °C
4: HCl / propan-2-ol / 3 h / 60 °C
View Scheme
dehydrolobeline

dehydrolobeline

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 90 percent / p-TsOH / benzene / 4 h / Heating
2: 61 percent / H2 / Pd/C / ethyl acetate / 4 h
3: 0.12 HCl / Heating
View Scheme
(2S,6S,2S)-2-<6-(2-hydroxy-2-phenylethyl)-1-methyl-1,2,5,6-tetrahydropyridin-2-yl>-1-phenylethan-<1,3>-dioxolane
208832-18-2

(2S,6S,2S)-2-<6-(2-hydroxy-2-phenylethyl)-1-methyl-1,2,5,6-tetrahydropyridin-2-yl>-1-phenylethan-<1,3>-dioxolane

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 61 percent / H2 / Pd/C / ethyl acetate / 4 h
2: 0.12 HCl / Heating
View Scheme
Lobeline hydrochloride
134-63-4

Lobeline hydrochloride

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; benzene40 mg
NSC 95097
552-72-7

NSC 95097

A

(2S)-Lobeline

(2S)-Lobeline

B

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With Pd(sparteine)Cl2; 6-methoxy-2-naphthol sodium salt; oxygen; (-)-sparteine In chloroform at 35℃; for 48h; Molecular sieve; optical yield given as %ee;
[(S)-2-[(2S,6R)-1-methyl-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethyl acetate]
1125824-45-4

[(S)-2-[(2S,6R)-1-methyl-6-(2-oxo-2-phenylethyl)piperidin-2-yl]-1-phenylethyl acetate]

lobeline
90-69-7

lobeline

Conditions
ConditionsYield
With hydrogenchloride; water In methanol Reflux;43 mg
propionyl chloride
79-03-8

propionyl chloride

lobeline
90-69-7

lobeline

cis-LPR hydrochloride
1217313-06-8

cis-LPR hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;96%
acetyl chloride
75-36-5

acetyl chloride

lobeline
90-69-7

lobeline

cis-LAC hydrochloride
1217888-95-3

cis-LAC hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;93%
2-Thiophenecarbonyl chloride
5271-67-0

2-Thiophenecarbonyl chloride

lobeline
90-69-7

lobeline

cis-LTH hydrochloride
1217313-11-5

cis-LTH hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;90%
benzoyl chloride
98-88-4

benzoyl chloride

lobeline
90-69-7

lobeline

cis-LBZ hydrochloride
1217313-00-2

cis-LBZ hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;90%
butyryl chloride
141-75-3

butyryl chloride

lobeline
90-69-7

lobeline

cis-LBU hydrochloride
1217313-07-9

cis-LBU hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;90%
benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LBS hydrochloride
1217313-12-6

cis-LBS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;90%
2-Naphthalenesulfonyl chloride
93-11-8

2-Naphthalenesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LINPS hydrochloride
1217313-18-2

cis-LINPS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;90%
lobeline
90-69-7

lobeline

benzenesulfonyl chloride
1939-99-7

benzenesulfonyl chloride

cis-LBNS hydrochloride
1217313-21-7

cis-LBNS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;90%
thiophene-2-sulfonyl chloride
16629-19-9

thiophene-2-sulfonyl chloride

lobeline
90-69-7

lobeline

cis-LTHS hydrochloride
1217313-17-1

cis-LTHS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;88%
1-Naphthalenesulfonyl chloride
85-46-1

1-Naphthalenesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LNPS hydrochloride
1217313-22-8

cis-LNPS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;88%
4-Fluorobenzenesulfonyl chloride
349-88-2

4-Fluorobenzenesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LFBS hydrochloride
1217313-15-9

cis-LFBS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;86%
isobutyryl chloride
79-30-1

isobutyryl chloride

lobeline
90-69-7

lobeline

cis-LIBU hydrochloride
1217313-09-1

cis-LIBU hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;86%
perfluoro-1-butanesulfonyl fluoride
2386-60-9

perfluoro-1-butanesulfonyl fluoride

lobeline
90-69-7

lobeline

cis-LBUS hydrochloride
1217313-20-6

cis-LBUS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;82%
4-methyl-benzoyl chloride
874-60-2

4-methyl-benzoyl chloride

lobeline
90-69-7

lobeline

cis-LTO hydrochloride
1217313-02-4

cis-LTO hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;80%
4-chlorobenzenesulfonyl chloride
98-60-2

4-chlorobenzenesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LCBS hydrochloride
1217313-14-8

cis-LCBS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;80%
4-Nitrobenzenesulfonyl chloride
98-74-8

4-Nitrobenzenesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LNBS hydrochloride
1217313-16-0

cis-LNBS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;78%
2-propanesulfonyl chloride
10147-37-2

2-propanesulfonyl chloride

lobeline
90-69-7

lobeline

cis-LIPS hydrochloride
1217313-19-3

cis-LIPS hydrochloride

Conditions
ConditionsYield
In tetrahydrofuran at 0℃; Inert atmosphere;72%
chromium(lll) acetate
1066-30-4

chromium(lll) acetate

lobeline
90-69-7

lobeline

Lobelanine
579-21-5

Lobelanine

water
7732-18-5

water

lobeline
90-69-7

lobeline

acetophenone
98-86-2

acetophenone

Conditions
ConditionsYield
at 110℃;
acetic acid
64-19-7

acetic acid

lobeline
90-69-7

lobeline

sodium amalgam

sodium amalgam

lobelanidine

lobelanidine

Conditions
ConditionsYield
at 10 - 15℃;

90-69-7Relevant articles and documents

Synthesis method of lobeline

-

Paragraph 0064; 0115-0120; 0121; 0164-0168; 0169; 0214-0218, (2019/02/04)

The invention discloses a synthesis method of lobeline and belongs to the technical field of organic synthesis. The synthesis method comprises the following steps: sequentially carrying out ring opening reaction, oxidization reaction, dehydration reaction, addition reaction, reduction reaction, protection reaction, substitution reaction, hydrolysis reaction, coupling reaction and hydrolysis ring closing reaction to prepare 2-[(2R,6S)-6-[(2S)-2-hydroxyl-2-phenethyl]-1-methylpiperidine]-1-acetophenone. According to the synthesis method disclosed by the invention, a whole technological route is simple, raw materials are cheap and easy to obtain, the cost is low, reaction conditions are mild, the operation is simple, the chiral purity is high and the yield is high; a chiral center is synthesized through simple chemical reaction and an expensive chiral catalyst is not used, so that the cost is reduced; in the whole technological route, the raw materials are cheap and easy to obtain, the cost is low, the technology is simple, the reaction conditions are mild, the operation is simple and the total yield is high.

Mannich-type Reactions of Cyclic Nitrones: Effective Methods for the Enantioselective Synthesis of Piperidine-containing Alkaloids

Lisnyak, Vladislav G.,Lynch-Colameta, Tessa,Snyder, Scott A.

, p. 15162 - 15166 (2018/10/26)

Even though there are dozens of biologically active 2-substituted and 2,6-disubstituted piperidines, only a limited number of approaches exist for their synthesis. Herein is described two Mannich-type additions to nitrones, one using β-ketoacids under catalyst-free conditions and another using methyl ketones in the presence of chiral thioureas, which can generate a broad array of such 2-substituted materials, as well as other ring variants, in the form of β-N-hydroxy-aminoketones. Both processes have broad scope, with the latter providing products with high enantioselectivity (up to 98 %). The combination of these methods, along with other critical steps, has enabled 8-step total syntheses of the 2,6-disubstituted piperidine alkaloids (?)-lobeline and (?)-sedinone.

2-[(2R, 6S)-6-[(2S)-2-hydroxy-2-phenethyl]-1-pipecoline]-1-hypnone synthesis method

-

Paragraph 0045; 0046; 0047; 0054; 0055, (2017/06/02)

The invention discloses a 2-[(2R, 6S)-6-[(2S)-2-hydroxy-2-phenethyl]-1-pipecoline]-1-hypnone synthesis method, and belongs to the field of organic synthesis. (1S, 2S)-1, 2-diphenyl diaminoethane serving as a raw material is subjected to acylation, substitution and the like to prepare chiral amine catalysts. A main route totally includes two steps: synthesizing glutaraldehyde, benzoyl acetic acid and methylamine hydrochloride to form cis-lobelanine; performing asymmetric selective reduction synthesis of 2-[(2R, 6S)-6-[(2S)-2-hydroxy-2-phenethyl]-1-pipecoline]-1-hypnone under mild reaction conditions and under the action of the catalysts. The raw material in the whole process route is cheap and easy to obtain, the catalysts can be recycled and can continue to be used, and the synthesis method is low in cost, simple in process, mild in reaction condition, convenient in operation and high in total yield.

Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters

Hojahmat, Marhaba,Horton, David B.,Norrholm, Seth D.,Miller, Dennis K.,Grinevich, Vladimir P.,Deaciuc, Agripina Gabriela,Dwoskin, Linda P.,Crooks, Peter A.

experimental part, p. 640 - 649 (2010/05/02)

Vesicular monoamine transporter-2 (VMAT2) is a viable target for development of pharmacotherapies for psychostimulant abuse. Lobeline (1) is a potent antagonist at α4β2* nicotinic acetylcholine receptors, has moderate affinity (Ki = 5.46 μM) for VMAT2, and is being investigated currently as a clinical candidate for treatment of psychostimulant abuse. A series of carboxylic acid and sulfonic acid ester analogs 2-20 of lobeline were synthesized and evaluated for interaction with α4β2* and α7* neuronal nicotinic acetylcholine receptors (nAChRs), the dopamine transporter (DAT), serotonin transporter (SERT) and VMAT2. Both carboxylic acid and sulfonic acid esters had low affinity at α7* nAChRs. Similar to lobeline (Ki = 4 nM), sulfonic acid esters had high affinity at α4β2* (Ki = 5-17 nM). Aromatic carboxylic acid ester analogs of lobeline (2-4) were 100-1000-fold less potent than lobeline at α4β2* nAChRs, whereas aliphatic carboxylic acid ester analogs were 10-100-fold less potent than lobeline at α4β2*. Two representative lobeline esters, the 10-O-benzoate (2) and the 10-O-benzenesulfonate (10) were evaluated in the 36Rb+ efflux assay using rat thalamic synaptosomes, and were shown to be antagonists with IC50 values of 0.85 μM and 1.60 μM, respectively. Both carboxylic and sulfonic acid esters exhibited a range of potencies (equipotent to 13-45-fold greater potency compared to lobeline) for inhibiting DAT and SERT, respectively, and like lobeline, had moderate affinity (Ki = 1.98-10.8 μM) for VMAT2. One of the more interesting analogs, p-methoxybenzoic acid ester 4, had low affinity at α4β2* nAChRs (Ki = 19.3 μM) and was equipotent with lobeline, at VMAT2 (Ki = 2.98 μM), exhibiting a 6.5-fold selectivity for VMAT2 over α4β2 nAChRs. Thus, esterification of the lobeline molecule may be a useful structural modification for the development of lobeline analogs with improved selectivity at VMAT2.

Synthesis of (-)-lobeline via enzymatic desymmetrization of lobelanidine

Chenevert, Robert,Morin, Pierre

experimental part, p. 1837 - 1839 (2009/05/26)

The bioactive alkaloid (-)-lobeline was synthesized via the stereoselective acylation (desymmetrization) of meso-lobelanidine by vinyl acetate in the presence of Candida antarctica lipase B.

Pd-catalyzed enantioselective aerobic oxidation of secondary alcohols: Applications to the total synthesis of alkaloids

Krishnan, Shyam,Bagdanoff, Jeffrey T.,Ebner, David C.,Ramtohul, Yeeman K.,Tambar, Uttam K.,Stoltz, Brian M.

supporting information; experimental part, p. 13745 - 13754 (2009/02/06)

Enantioselective syntheses of the alkaloids (-)-aurantioclavine, (+)-amurensinine, (-)-lobeline, and (-)- and (+)-sedamine are described. The syntheses demonstrate the effectiveness of the Pd-catalyzed asymmetric oxidation of secondary alcohols in diverse contexts and the ability of this methodology to set the absolute configuration of multiple stereocenters in a single operation. The utility of an aryne C-C insertion reaction in accessing complex polycyclic frameworks is also described.

Process for manufacturing of chiral lobelin

-

Page/Page column 2-3, (2008/06/13)

The present invention relates to a shortened process for preparing L-lobeline by rhodium-catalysed asymmetric hydrogenation on an industrial scale.

A highly stereoselective asymmetric synthesis of (-)-lobeline and (-)-sedamine

Felpin, Francois-Xavier,Lebreton, Jacques

, p. 9192 - 9199 (2007/10/03)

A highly stereoselective asymmetric synthesis of (-)-sedamine and (-)-lobeline is described from benzaldehyde in 16 and 17 steps with an overall yield of 20% and 14%, respectively. The key intermediate syn-3,4-epoxyalcohol was prepared in a highly diastereomeric fashion (>99% ee, dr) and served as a common intermediate for both alkaloids.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 90-69-7